Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

Subcortical volumes across the lifespan: Data from 18,605 healthy individuals aged 3–90 years

Karolinska Schizophrenia Project (KaSP)

Abstract

Age has a major effect on brain volume. However, the normative studies available are constrained by small sample sizes, restricted age coverage and significant methodological variability. These limitations introduce inconsistencies and may obscure or distort the lifespan trajectories of brain morphometry. In response, we capitalized on the resources of the Enhancing Neuroimaging Genetics through Meta-Analysis (ENIGMA) Consortium to examine age-related trajectories inferred from cross-sectional measures of the ventricles, the basal ganglia (caudate, putamen, pallidum, and nucleus accumbens), the thalamus, hippocampus and amygdala using magnetic resonance imaging data obtained from 18,605 individuals aged 3–90 years. All subcortical structure volumes were at their maximum value early in life. The volume of the basal ganglia showed a monotonic negative association with age thereafter; there was no significant association between age and the volumes of the thalamus, amygdala and the hippocampus (with some degree of decline in thalamus) until the sixth decade of life after which they also showed a steep negative association with age. The lateral ventricles showed continuous enlargement throughout the lifespan. Age was positively associated with inter-individual variability in the hippocampus and amygdala and the lateral ventricles. These results were robust to potential confounders and could be used to examine the functional significance of deviations from typical age-related morphometric patterns.

OriginalspracheEnglisch
ZeitschriftHuman Brain Mapping
Jahrgang43
Ausgabenummer1
Seiten (von - bis)452-469
Seitenumfang18
ISSN1065-9471
DOIs
PublikationsstatusVeröffentlicht - 01.2022

Fördermittel

H.‐J. G.: Travel grants and speaker honoraria from Fresenius Medical Care, Neuraxpharm, Servier and Janssen Cilag; research funding from Fresenius Medical Care. O. A. A.: Consultant to HealthLytix, speaker honorarium from Lundbeck. A. M. D.: Founder and member of the Scientific Advisory Board CorTechs Labs, Inc where he holds equity; member of the Scientific Advisory of Human Longevity Inc; research grants with General Electric Healthcare. National Institute of Mental Health, Grant/Award Numbers: MH104284, MH116147, R01MH113619, R01 MH090553, R01MH117014, R01MH042191; Karolinska Institutet; Stockholm County Council; Southern and Eastern Norway Regional Health Authority; German Centre for Cardiovascular Research; DZHK; Siemens Healthineers; University of Queensland; US National Institute of Child Health and Human Development, Grant/Award Number: RO1HD050735; Australian National Health and Medical Research Council; Eunice Kennedy Shriver National Institute of Child Health & Human Development; National Institute on Drug Abuse, Grant/Award Numbers: UL1 TR000153, 1 U24 RR025736‐01, 1 U24 RR021992; Brain Injury Fund Research Grant Program; Indiana State Department of Health Spinal Cord; Parents Against Childhood Epilepsy; Epilepsy Therapy Project, Fight Against Childhood Epilepsy and Seizures; Epilepsy Foundation; American Epilepsy Society; Knut and Alice Wallenberg Foundation; European Community's Horizon 2020 Programme; Vici Innovation Program; NWO Brain & Cognition Excellence Program; Netherlands Organization for Scientific Research; Hersenstichting Nederland; Netherlands Organization for Health Research and Development; Geestkracht Programme of the Dutch Health Research Council, Grant/Award Number: 10‐000‐1001; Universiteit Utrecht; FP7 Ideas: European Research Council; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; National Center for Advancing Translational Sciences; National Institutes of Health; National Center for Research Resources; Consortium grant, Grant/Award Number: U54 EB020403; U.S. National Institutes of Health, Grant/Award Numbers: R01 CA101318, P30 AG10133, R01 AG19771; Medical Research Council, Grant/Award Number: G0500092; Fundación Instituto de Investigación Marqués de Valdecilla, Grant/Award Numbers: API07/011, NCT02534363, NCT0235832; Instituto de Salud Carlos III, Grant/Award Numbers: PI14/00918, PI14/00639, PI060507, PI050427, PI020499; the Research Council, Grant/Award Number: 223273; South Eastern Norway Regional Health Authority, Grant/Award Numbers: 2017‐112, 2019107; Swedish Research Council; European Community's Seventh Framework Programme, Grant/Award Number: 602450; King's College London; South London and Maudsley NHS Foundation Trust; Biomedical Research Centre; National Institute for Health Research Funding information

TrägerTrägernummer
Epilepsy Therapy Project
European Community's Horizon 2020 Programme
Fight Against Childhood Epilepsy and Seizures
Geestkracht Programme of the Dutch Health Research Council10‐000‐1001
National Institute for Health Research Funding information
Netherlands Organization for Health Research and Development
National Institutes of Health
National Institute of Mental HealthMH104284, R01 MH090553, R01MH113619, MH116147, R01MH042191, R01MH117014
National Institute on Drug Abuse1 U24 RR021992
Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentRO1HD050735
National Center for Research ResourcesR01 CA101318, P30 AG10133, R01 AG19771, U54 EB020403
National Center for Research Resources
American Epilepsy Society
Epilepsy Institutes of the Netherlands Foundation
National Center for Advancing Translational Sciences (NCATS)UL1TR000153
Indiana State Department of Health
South London and Maudsley NHS Foundation Trust
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Deutsches Zentrum für Herz-Kreislaufforschung
Seventh Framework Programme602450
Seventh Framework Programme
Parents Against Childhood Epilepsy
NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research
Fresenius Medical Care North America
Medical Research CouncilG0500092
King’s College London
European Research Council
National Health and Medical Research Council
The University of Queensland
Universiteit Utrecht
Nederlandse Organisatie voor Wetenschappelijk Onderzoek
Karolinska Institutet
Knut och Alice Wallenbergs Stiftelse
Stockholms Läns Landsting
Vetenskapsrådet
Instituto de Salud Carlos IIIPI060507, PI050427, PI14/00639, PI020499, PI14/00918
Instituto de Salud Carlos III
Seventh Framework Programme
Norges Forskningsråd223273
Norges Forskningsråd
Helse Sør-Øst RHF2017‐112, 2019107
Helse Sør-Øst RHF
Hersenstichting
Instituto de Investigación Marqués de ValdecillaNCT0235832, API07/011, NCT02534363
Instituto de Investigación Marqués de Valdecilla

    UN SDGs

    Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

    1. SDG 3 – Gesundheit und Wohlergehen
      SDG 3 – Gesundheit und Wohlergehen

    Strategische Forschungsbereiche und Zentren

    • Forschungsschwerpunkt: Gehirn, Hormone, Verhalten - Center for Brain, Behavior and Metabolism (CBBM)

    DFG-Fachsystematik

    • 2.23-10 Klinische Psychiatrie, Psychotherapie und Kinder- und Jugendpsychiatrie

    Fingerprint

    Untersuchen Sie die Forschungsthemen von „Subcortical volumes across the lifespan: Data from 18,605 healthy individuals aged 3–90 years“. Zusammen bilden sie einen einzigartigen Fingerprint.

    Zitieren